Endocrine Abstracts

Aim: To assess the effects of a continuous overnight infusion of two doses of UAG (3&10 μg UAG/kg.hr-1) versus placebo in a double blind cross-over study on AG levels, as well on glucose and insulin response to a standard breakfast meal (SBM) in 8 overweight patients with type 2 diabetes (HbA1c 6.5-7.5%).Methods: During these 3 admissions, in randomized order, all subjects received either placebo, or UAG 3 μg/kg.hr-1 or UAG 10 μg/kg.hr...

In Europe more than 50 million adults are diabetic. Of these, 90–95% have type 2 diabetes (T2D). It is also recognized that an even larger population is insulin resistant and it is thought that treatment at this early phase of the metabolic syndrome may prevent the occurrence of overt diabetes and associated pathologies. We are in the process of developing unacylated ghrelin (UAG) analogues as therapeutics for T2D. Towards this goal, we have used a mouse protocol in which...